臨床試驗

Advanta VXT and Flixene PMCF Registry

NCT：NCT07161583 · RECRUITING

NCT IDNCT07161583

狀態RECRUITING

開始日期2025-09-25

SponsorAtrium Medical Corporation (INDUSTRY)

First posted2025-09-08

Last updated2026-09-11

簡要摘要

The purpose of the registry is to evaluate the long-term safety and performance of Advanta VXT and Flixene vascular grafts for repair or replacement of peripheral arteries. This registry is also intended to provide further data on the clinical usefulness of the Advanta VXT and Flixene vascular grafts.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。